Fulcrum Therapeutics Inc., $FULC , up $2.10 to $6.02
Option volume is running at nearly 14x the daily average on this clinical-stage biopharmaceutical company which is primarily being driven by activity on two contracts on the September 15th expiration:
6.00 call (volume is 3,127 vs. open interest of 0): The majority of the transactions on this contract consisted of various-sized blocks that were being bought at various times for between $0.35-0.55 each, which suggests bullish intent.
7.50 call (volume is 1,833 vs. open interest of 126): The majority of the transactions on this contract consisted of various-sized blocks that were being bought at various times for between $0.20-0.35 each, which suggests bullish intent.
